caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1235300658

Kevin Chen

PRACTICEOAKLAND MEDICAL GROUP, INC.See all providers at this practice →
Internal MedicineOakland, CAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.
REFERRAL NETWORK

Where Kevin Chen's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 9 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
SUTTER EAST BAY HOSPITALS1739
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
Unilab Corporation
Clinical Laboratory · Sacramento, CA
172478
SUTTER EAST BAY HOSPITALS71151
SUTTER EAST BAY HOSPITALS1643
Unilab Corporation
Clinical Laboratory · San Jose, CA
1561
Less Chafen
Diagnostic Radiology · Walnut Creek, CA
1520
Laboratory Corporation Of America
Clinical Laboratory · San Diego, CA
1525
Michael Wang
Ophthalmology · Oakland, CA
1318
Kathryn Klima
Diagnostic Radiology · Oakland, CA
1221
Richard Brenner
Diagnostic Radiology · San Francisco, CA
1114
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
Total Rx claims
8,584
Beneficiaries
—
Total drug cost
$371K
Distinct drugs
134
Brand share
21.6%
Top prescribed drugs
Atorvastatin Calcium721 claims
Amlodipine Besylate441 claims
Lisinopril364 claims
Losartan Potassium330 claims
Levothyroxine Sodium307 claims